Improved outcomes seen with ventricular assist devices

Improved outcomes seen with ventricular assist devices

(HealthDay)—Among Medicare patients receiving implantation of ventricular assist devices (VADs) for advanced heart failure, mortality has decreased, but readmission rates did not change, according to research published online Jan. 29 in the Journal of the American College of Cardiology.

Prateeti Khazanie, M.D., M.P.H., of Duke University in Durham, N.C., and colleagues retrospectively analyzed data for all Medicare fee-for-service patients who received an implantable VAD between 2006 and 2011 (2,507 patients) to examine trends in mortality and .

The researchers found that, during the study period, in-hospital mortality decreased from 30 to 10 percent (P < 0.001), one-year mortality decreased from 42 to 26 percent (P < 0.001), and all-cause readmission rate remained frequent, with a slight change from 82 to 81 percent (P = 0.70). These patterns persisted after covariate adjustment. Low procedure volume was associated with increased risks for in-hospital mortality (risk ratio, 1.72; 95 percent confidence interval [CI], 1.28 to 2.33) and one-year mortality (risk ratio, 1.55; 95 percent CI, 1.24 to 1.93) but not readmission.

"Short-term and long-term mortality after VAD implantation among Medicare beneficiaries improved, but readmission remained common," the authors write. "Higher volume of VAD implants was associated with lower risk of mortality but not readmission."

Two of the study authors disclosed financial ties to Thoratec.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Hypertension linked to post-cervical fusion readmission

Jan 22, 2014

(HealthDay)—The readmission rate following anterior cervical discectomy and fusion (ACDF) is 2.5 percent, and hypertension may increase the likelihood of readmission, according to a study published in the ...

Clopidogrel after MI less effective in diabetes patients

Sep 05, 2012

(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue ...

Recommended for you

Results of RIBS IV trial reported

7 hours ago

A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results ...

Results of DKCRUSH-VI trial reported

7 hours ago

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The DKCRUSH-VI clinical trial ...

Results of IVUS-CTO trial reported at TCT 2014

7 hours ago

A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous ...

Results of OCT STEMI trial reported at TCT 2014

7 hours ago

The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ...

INR variability predicts warfarin adverse effects

13 hours ago

(HealthDay)—Unstable anticoagulation predicts warfarin adverse effects regardless of time in therapeutic range, according to a study published online Sept. 2 in Circulation: Cardiovascular Quality and Ou ...

User comments